NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Alpine Immune Sciences Inc (NASDAQ: ALPN)

 
ALPN Technical Analysis
3
As on 9th Jun 2023 ALPN STOCK Price closed @ 10.27 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.34 & Buy for SHORT-TERM with Stoploss of 9.47 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALPNSTOCK Price

Open 10.40 Change Price %
High 10.59 1 Day -0.10 -0.96
Low 10.19 1 Week 0.31 3.11
Close 10.27 1 Month 3.03 41.85
Volume 64241 1 Year -3.68 -26.38
52 Week High 13.95 | 52 Week Low 5.45
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ALPN
Daily Charts
ALPN
Intraday Charts
Whats New @
Bazaartrend
ALPN
Free Analysis
 
ALPN Important Levels Intraday
RESISTANCE11.04
RESISTANCE10.79
RESISTANCE10.64
RESISTANCE10.49
SUPPORT10.05
SUPPORT9.90
SUPPORT9.75
SUPPORT9.50
 
ALPN Forecast May 2024
4th UP Forecast18.79
3rd UP Forecast16.06
2nd UP Forecast14.37
1st UP Forecast12.68
1st DOWN Forecast7.86
2nd DOWN Forecast6.17
3rd DOWN Forecast4.48
4th DOWN Forecast1.75
 
ALPN Weekly Forecast
4th UP Forecast12.72
3rd UP Forecast11.93
2nd UP Forecast11.45
1st UP Forecast10.96
1st DOWN Forecast9.58
2nd DOWN Forecast9.09
3rd DOWN Forecast8.61
4th DOWN Forecast7.82
 
ALPN Forecast2024
4th UP Forecast28.73
3rd UP Forecast22.81
2nd UP Forecast19.15
1st UP Forecast15.49
1st DOWN Forecast5.05
2nd DOWN Forecast1.39
3rd DOWN Forecast-2.27
4th DOWN Forecast-8.19
 
 
ALPN Other Details
Segment EQ
Market Capital 356875328.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALPN Address
ALPN
 
ALPN Latest News
 
Your Comments and Response on Alpine Immune Sciences Inc
 
ALPN Business Profile
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated autoimmune/inflammatory diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the research, development, and commercialization of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington. Address: 188 East Blaine Street, Seattle, WA, United States, 98102
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service